Return to homepagePandemic Pact

VOICE: Vaccination against cOvid In CancEr

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04301E+13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $3,626,819.6

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)

  • Principal Investigator

    Prof dr EGE de Vries

  • Research Location

    Netherlands

  • Lead Research Institution

    Universitair Medisch Centrum Groningen

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidityOther

  • Occupations of Interest

    Unspecified

Abstract

RESEARCH QUESTION In patients with cancer, the disease and immunotherapy and chemotherapy may significantly impact the ability to develop an effective immune-response to COVID-19 vaccination and could even increase the risk of adverse events. OBJECTIVE To assess immune-response and adverse events after vaccination with one vaccine against COVID-19 in patients with cancer treated with immunotherapy and/or chemotherapy.